Zentalis Pharmaceuticals
ZNTL
#9105
Rank
$85.57 M
Marketcap
$1.19
Share price
14.58%
Change (1 day)
-91.85%
Change (1 year)

P/S ratio for Zentalis Pharmaceuticals (ZNTL)

P/S ratio as of April 2025 (TTM): 1.28

According to Zentalis Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.2556. At the end of 2024 the company had a P/S ratio of 3.23.

P/S ratio history for Zentalis Pharmaceuticals from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.23
2023N/A
2022N/A
2021N/A
2020N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
92.5 7,137.37%๐Ÿ‡บ๐Ÿ‡ธ USA
1.67 30.46%๐Ÿ‡บ๐Ÿ‡ธ USA